Fig. 3From: Potential DNA methylation biomarkers for the detection of clear cell renal cell carcinoma identified by a whole blood-based epigenome-wide association studyBox plots with jitter of the DNAm level. Comparison of DNAm levels of six ccRCC-associated CpGs between ccRCC patients and TMM controls in the a discovery phase and b replication phase. p-values were obtained using two-tailed Student's tests (p < 0.05). DNAm, DNA methylation; ccRCC, clear cell renal cell carcinoma; TMM, Tohoku Medical MegabankBack to article page